Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concentra Group Holdings Parent (CON) Cash from Financing Activities (2023 - 2026)

Concentra Group Holdings Parent (CON) reported Cash from Financing Activities of -$24.4 million for Q1 2026, down 116.05% year-over-year from $151.9 million in Q1 2025, and up 64.47% on a QoQ basis from -$68.6 million in Q4 2025.

Concentra Group Holdings Parent (CON) has 4 years of Cash from Financing Activities data on file, last reported at -$24.4 million in Q1 2026.

  • Quarterly Cash from Financing Activities fell 116.05% year-over-year to -$24.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$144.2 million (down 238.01% YoY) and the FY2025 annual result came in at $32.1 million, up 162.3% from the prior year.
  • Cash from Financing Activities advanced to -$24.4 million in Q1 2026 per CON's latest filing, from -$68.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $151.9 million in Q1 2025 and bottomed at -$68.6 million in Q4 2025.
  • The 4-year median for Cash from Financing Activities is -$30.6 million (2024), against an average of -$12.4 million.
  • Peak annual rise in Cash from Financing Activities reached 3812.22% in 2025, while the deepest fall reached 272.24% in 2025.
  • Tracing CON's Cash from Financing Activities over 4 years: stood at -$40.3 million in 2023, then increased by 24.08% to -$30.6 million in 2024, then plunged by 124.23% to -$68.6 million in 2025, then jumped by 64.47% to -$24.4 million in 2026.
  • Per Business Quant, the three latest CON Cash from Financing Activities figures stand at -$24.4 million (Q1 2026), -$68.6 million (Q4 2025), and -$64.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -830.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -1.24 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn -213.34 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn -102.50 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 6.65 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -221.89 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -242.57 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -108.09 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -67.71 Mn
10 Concentra Group Holdings Parent 3.13 Bn 3.07 Bn 170.47 Mn -24.37 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -24.37 Mn
Mar 31, 2026 -24.37 Mn
Dec 31, 2025 -68.60 Mn
Dec 31, 2025 -68.60 Mn
Sep 30, 2025 -64.09 Mn
Sep 30, 2025 -64.09 Mn
Jun 30, 2025 12.89 Mn
Jun 30, 2025 12.89 Mn
Mar 31, 2025 151.90 Mn
Mar 31, 2025 151.90 Mn
Dec 31, 2024 -30.60 Mn
Dec 31, 2024 -30.60 Mn
Sep 30, 2024 37.21 Mn
Sep 30, 2024 37.21 Mn
Jun 30, 2024 -54.05 Mn
Jun 30, 2024 -54.05 Mn
Mar 31, 2024 -4.09 Mn
Mar 31, 2024 -4.09 Mn
Dec 31, 2023 -40.30 Mn
Dec 31, 2023 -40.30 Mn
Sep 30, 2023 -52.70 Mn
Sep 30, 2023 -52.70 Mn